CTKB FY 2025 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CTKBCytek Biosciences, Inc.

$553M

FY 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$201M+0.5% YoY

Gross Profit

$104M51.8% margin

Operating Income

-$40M-20.0% margin

Net Income

-$67M-33.0% margin

EPS (Diluted)

$-0.52

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$9M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$462M

Total Liabilities

$120M

Stockholders' Equity

$342M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$201M	$200M	+0.5%
Gross Profit	$104M	$111M	-6.0%
Operating Income	-$40M	-$21M	-96.8%
Net Income	-$67M	-$6M	-1005.3%